New Amsterdam Partners’s Regeneron Pharmaceuticals REGN Stock Holding History

New Amsterdam Partners’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$368K	Sell	896 -32	-3%	-$13.2K	0.14%	87
2018 Q4	$347K	Sell	928 -6	-0.6%	-$2.2K	0.11%	93
2018 Q3	$377K	Sell	934 -288	-24%	-$110K	0.1%	96
2018 Q2	$422K	Sell	1,222 -587	-32%	-$184K	0.1%	93
2018 Q1	$623K	Buy	+1,809	New	+$629K	0.14%	93
2017 Q4	–	Sell	-1,143	Closed	-$511K	–	126
2017 Q3	$511K	Hold	1,143	–	–	0.11%	100
2017 Q2	$561K	Sell	1,143 -6	-0.5%	-$2.63K	0.12%	95
2017 Q1	$445K	Buy	+1,149	New	+$426K	0.11%	108

Other funds holding REGN

Capital World Investors

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Loomis, Sayles & Company

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Harris Associates

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Wellington Management Group

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Sands Capital Management

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

T. Rowe Price Associates

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return